J. D. McDermed et al., J. Med. Chem. 1975, 18(4), 362-367: "Synthesis and Pharmacology of some 2-Aminotetralines. Dopamine receptor agonists". |
A. M. Johansson et al., Molecular Pharmacology, 1986, 30, 258-269: "2-aminotetralins: affinities for dopamine D.sub.2 receptors, molecular structures and conformational preferences". |
Anders Karlent et al., J. Med. Chem., 1989, 32, 765-774: "Topography and conformational preferences of 6,7,8,9-tetrahydro-1-hydroxy-N,N-dipropy-5H-benzocyclohepten-6-ylamine. A rationale for the dopaminergic inactivity". |
J. G. Cannon et al., J. Med. Chem., 1984, 27, 922-923: "Catechol Derivatives of 6-Aminobenzocycloheptene: Assessment of Dopaminergic Effects". |
J. G. Cannon et al., J. Med. Chem. 1972, 15(4), 348-350: "Centrally Acting Emetics. 6. Derivatives of beta-Naphthylamine and 2-Indanamine". |
Michele Bernier, et al., Am. J. Physiol., 1989 256, H21-H31: "Ischemia-induced and reperfusion-induced arrhythmias: importance of heart rate". |